MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.cct.2025.108135

Медицинская библиотека · Contemporary clinical trials · 2025

Addressing sleep apnea post-stroke and transient ischemic attack (ASAP) clinical trial design features: Inclusion of usual care control sites and electronic health record data validation.

Bravata Dawn M, Myers Laura J, Perkins Anthony J, Sexson Ali E, Daggy Joanne K, Taylor Stanley E, Burrone Laura, Koo Brian B, Miech Edward J, Rattray Nicholas A, Story K Maya, Waddell Kimberly, Ding Qinglan, Sico Jason J

СтатьяРандомизированное исследованиеПеревод в очереди

Аннотация

BACKGROUND

Addressing Sleep Apnea Post-Stroke and TIA (ASAP) evaluated a quality improvement (QI) intervention to increase sleep apnea testing among patients with ischemic stroke or transient ischemic attack (TIA). We describe ASAP methods highlighting two features: inclusion of usual care control sites and validation of electronic health record (EHR) data.

METHODS

ASAP was a stepped-wedge cluster-randomized clinical trial at N = 6 intervention sites augmented with N = 30 control sites to evaluate the effectiveness, implementation, sustainability, and business case of a quality improvement intervention to increase sleep apnea testing among stroke/TIA patients. The study period included the COVID-19 pandemic and an international device recall. EHR data were compared with chart review for cerebrovascular diagnosis, sleep study eligibility, sleep study receipt, and patient characteristics. EHR data accuracy (ACC) was assessed as: (true positives + true negatives)/(true positives + false positives + true negatives + false negatives).

RESULTS

During the baseline period (May 2019-February 2021), the average 30-day diagnostic rate was 2.0 % (implementation sites) and 1.3 % (control sites). Among N = 1658 implementation site patients, the index event was stroke in 78.7 %. EHR data accuracy was high for cerebrovascular diagnoses (ACC 0.918-0.953), sleep study receipt (ACC 0.949), and patient characteristics (0.898-0.996). EHR data accuracy was lower for sleep study eligibility (ACC 0.850).

CONCLUSIONS

The addition of control sites to stepped-wedge trials allows for intervention evaluation within the context of potential temporal trends influencing outcomes. EHR data can be used to evaluate sleep apnea diagnostic testing after ischemic stroke or TIA. Trial registration ClinicalTrials.govNCT04322162 Date of trial registration: 04/02/2020.

Для цитирования: Bravata Dawn M, Myers Laura J, Perkins Anthony J, Sexson Ali E, Daggy Joanne K, Taylor Stanley E, Burrone Laura, Koo Brian B, Miech Edward J, Rattray Nicholas A, Story K Maya, Waddell Kimberly, Ding Qinglan, Sico Jason J. Addressing sleep apnea post-stroke and transient ischemic attack (ASAP) clinical trial design features: Inclusion of usual care control sites and electronic health record data validation.. Contemporary clinical trials. 2025. DOI: 10.1016/j.cct.2025.108135.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.